# RGS16

## Overview
RGS16 is a gene that encodes the protein regulator of G protein signaling 16, which is a member of the regulator of G protein signaling (RGS) family. This protein functions as a GTPase-activating protein (GAP) that plays a critical role in the modulation of G protein-coupled receptor (GPCR) signaling pathways. By accelerating the hydrolysis of GTP to GDP on Gα subunits, RGS16 effectively terminates GPCR signaling, thereby influencing various cellular processes such as cell proliferation, differentiation, and migration (Tian2022Functions; Ross2000GTPaseActivating). The protein is characterized by a conserved RGS domain, which is essential for its interaction with Gα subunits and its regulatory functions (Li2023RGS). RGS16 is expressed in multiple tissues, including the retina and liver, and is involved in regulating visual signaling pathways, circadian rhythms, and metabolic processes (Tian2022Functions; Nakagawa2020TimeRestricted). Its dysregulation has been implicated in various diseases, including cancers and immune disorders, highlighting its potential as a biomarker and therapeutic target (Tian2022Functions; Huang2020RGS16).

## Structure
RGS16 is a member of the B/R4 subfamily of RGS proteins, characterized by a conserved RGS domain of approximately 120 amino acids. This domain is crucial for its function as a GTPase-activating protein (GAP), which accelerates the hydrolysis of GTP on Gα subunits, thereby terminating G protein signaling (Li2023RGS; Tian2022Functions). The RGS domain consists of nine α-helices that form two subdomains, facilitating interaction with Gα subunits (Li2023RGS).

The primary structure of RGS16 includes a core RGS structural domain between amino acids 62 and 180, which is highly conserved across species (Tian2022Functions). The protein also features a unique membrane-binding domain at the NH2 terminus, essential for its membrane association and biological activity (Tian2022Functions).

RGS16 undergoes post-translational modifications such as phosphorylation and palmitoylation, which influence its activity and membrane localization. Phosphorylation at specific tyrosine residues can modulate its GAP activity and stability, while palmitoylation affects its membrane localization (Tian2022Functions).

The tertiary structure of RGS16 involves the folding of the RGS domain, which is critical for its interaction with Gα subunits, contributing to its role in GTP hydrolysis and signaling inactivation (Tesmer2009Chapter). The protein's interaction with multifunctional proteins like 14-3-3 can block its interaction with Gα, affecting G protein-mediated signaling (Tian2022Functions).

## Function
RGS16, a member of the RGS protein family, functions as a GTPase-activating protein (GAP) for Gα subunits, accelerating the hydrolysis of GTP to GDP and thereby terminating G protein-coupled receptor (GPCR) signaling. This activity is crucial for modulating the intensity and duration of GPCR-mediated signaling pathways, which are involved in various cellular processes such as cell proliferation, differentiation, and migration (Tian2022Functions; Ross2000GTPaseActivating).

RGS16 is expressed in multiple tissues, including the retina, pituitary gland, bone marrow, and liver, and plays a significant role in regulating visual signaling pathways and circadian rhythms. In the suprachiasmatic nucleus (SCN), RGS16 is involved in the regulation of the circadian clock by modulating cAMP signaling, which is essential for maintaining circadian rhythms (Tian2022Functions; Nakagawa2020TimeRestricted).

In addition to its role in circadian regulation, RGS16 influences metabolic processes such as fatty acid oxidation and lipid synthesis, and is involved in pancreatic function, affecting insulin secretion and β-cell proliferation. These functions highlight its importance in maintaining metabolic homeostasis and its potential implications for diabetes treatment (Tian2022Functions).

## Clinical Significance
Alterations in the expression or function of the RGS16 gene have been implicated in various diseases, particularly cancers and immune disorders. In breast cancer, RGS16 is often downregulated due to allelic imbalance and promoter methylation, which enhances PI3K signaling and promotes tumor cell proliferation and resistance to tyrosine kinase inhibitors (Wiechec2008A; Liang2009RGS16). In gliomas, higher RGS16 expression is associated with increased tumor grade and poorer prognosis, suggesting its role in promoting glioma progression through pathways like PD1/PD-L1 and TIM3 (Huang2020RGS16).

RGS16 also plays a role in hematologic malignancies, as it is aberrantly expressed in hyperdiploid acute lymphoblastic leukemia (Tian2022Functions). In pancreatic cancer, reduced RGS16 expression correlates with poor prognosis, while its overexpression inhibits cancer progression (Tian2022Functions). The gene's involvement in immune responses is highlighted by its modulation of inflammatory pathways and its role in diseases like pulmonary and allergic inflammation (Tian2022Functions). These findings suggest that RGS16 could serve as a potential biomarker and therapeutic target in various cancers and immune-related conditions.

## Interactions
RGS16 interacts with various Gα subunits of heterotrimeric G proteins, specifically regulating the Gαi and Gαo subfamilies. These interactions involve specific residues in the Switch regions and sometimes the helical domain of the Gαi/o proteins, with the aA helix and aB-aC loop being notable contact points (Baltoumas2013Interactions). RGS16 is also implicated in interactions with the p53 tumor suppressor protein, where it is upregulated in human colon carcinoma cells, suggesting a role in cancer pathways (Hepler1999Emerging).

RGS16's activity and stability are influenced by phosphorylation at specific sites, such as serine 194, serine 53, and tyrosine 168. Phosphorylation at Tyr 168 enhances both its GTPase-activating protein (GAP) activity and stability (Li2023RGS). The protein is subject to degradation through the ubiquitin proteasome pathway and the N-end rule pathway, which further regulates its stability and function (Li2023RGS).

RGS16 also exhibits a bell-shaped concentration-dependence in its GAP activity, indicating auto-antagonism at high concentrations, as observed in assays with an M1 muscarinic receptor-Gα11 fusion protein (AbramowNewerly2006RGS). This behavior highlights the complex regulatory role of RGS16 in GPCR signaling pathways.


## References


[1. (Tian2022Functions) Miaomiao Tian, Yan Ma, Tao Li, Nijin Wu, Jiaqi Li, Huimin Jia, Meizhu Yan, Wenwen Wang, Hongjun Bian, Xu Tan, and Jianni Qi. Functions of regulators of g protein signaling 16 in immunity, inflammation, and other diseases. Frontiers in Molecular Biosciences, September 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.962321, doi:10.3389/fmolb.2022.962321. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.962321)

[2. (Hepler1999Emerging) John R Hepler. Emerging roles for rgs proteins in cell signalling. Trends in Pharmacological Sciences, 20(9):376–382, September 1999. URL: http://dx.doi.org/10.1016/s0165-6147(99)01369-3, doi:10.1016/s0165-6147(99)01369-3. This article has 209 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0165-6147(99)01369-3)

[3. (Li2023RGS) Lin Li, Qiang Xu, and Chao Tang. Rgs proteins and their roles in cancer: friend or foe? Cancer Cell International, April 2023. URL: http://dx.doi.org/10.1186/s12935-023-02932-8, doi:10.1186/s12935-023-02932-8. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-023-02932-8)

[4. (AbramowNewerly2006RGS) Maria Abramow-Newerly, Anju A. Roy, Caroline Nunn, and Peter Chidiac. Rgs proteins have a signalling complex: interactions between rgs proteins and gpcrs, effectors, and auxiliary proteins. Cellular Signalling, 18(5):579–591, May 2006. URL: http://dx.doi.org/10.1016/J.CELLSIG.2005.08.010, doi:10.1016/j.cellsig.2005.08.010. This article has 300 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/J.CELLSIG.2005.08.010)

[5. (Nakagawa2020TimeRestricted) Shumpei Nakagawa, Khanh Tien Nguyen Pham, Xinyan Shao, and Masao Doi. Time-restricted g-protein signaling pathways via gpr176, gz, and rgs16 set the pace of the master circadian clock in the suprachiasmatic nucleus. International Journal of Molecular Sciences, 21(14):5055, July 2020. URL: http://dx.doi.org/10.3390/ijms21145055, doi:10.3390/ijms21145055. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21145055)

[6. (Ross2000GTPaseActivating) Elliott M. Ross and Thomas M. Wilkie. Gtpase-activating proteins for heterotrimeric g proteins: regulators of g protein signaling (rgs) and rgs-like proteins. Annual Review of Biochemistry, 69(1):795–827, June 2000. URL: http://dx.doi.org/10.1146/annurev.biochem.69.1.795, doi:10.1146/annurev.biochem.69.1.795. This article has 940 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1146/annurev.biochem.69.1.795)

[7. (Wiechec2008A) Emilia Wiechec, Jens Overgaard, and Lise Lotte Hansen. A fragile site within the hpc1 region at 1q25.3 affecting rgs16, rgsl1, and rgsl2 in human breast carcinomas. Genes, Chromosomes and Cancer, 47(9):766–780, June 2008. URL: http://dx.doi.org/10.1002/gcc.20578, doi:10.1002/gcc.20578. This article has 23 citations.](https://doi.org/10.1002/gcc.20578)

[8. (Huang2020RGS16) Ruoyu Huang, Guanzhang Li, Zheng Zhao, Fan Zeng, Kenan Zhang, Yanwei Liu, Kuanyu Wang, and Huimin Hu. Rgs16 promotes glioma progression and serves as a prognostic factor. CNS Neuroscience &amp; Therapeutics, 26(8):791–803, April 2020. URL: http://dx.doi.org/10.1111/cns.13382, doi:10.1111/cns.13382. This article has 26 citations.](https://doi.org/10.1111/cns.13382)

[9. (Liang2009RGS16) Genqing Liang, Geetanjali Bansal, Zhihui Xie, and Kirk M. Druey. Rgs16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. Journal of Biological Chemistry, 284(32):21719–21727, August 2009. URL: http://dx.doi.org/10.1074/jbc.m109.028407, doi:10.1074/jbc.m109.028407. This article has 62 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.028407)

[10. (Tesmer2009Chapter) John J.G. Tesmer. Chapter 4 Structure and Function of Regulator of G Protein Signaling Homology Domains, pages 75–113. Elsevier, 2009. URL: http://dx.doi.org/10.1016/S1877-1173(09)86004-3, doi:10.1016/s1877-1173(09)86004-3. This article has 77 citations.](https://doi.org/10.1016/S1877-1173(09)86004-3)

[11. (Baltoumas2013Interactions) Fotis A. Baltoumas, Margarita C. Theodoropoulou, and Stavros J. Hamodrakas. Interactions of the α-subunits of heterotrimeric g-proteins with gpcrs, effectors and rgs proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials. Journal of Structural Biology, 182(3):209–218, June 2013. URL: http://dx.doi.org/10.1016/j.jsb.2013.03.004, doi:10.1016/j.jsb.2013.03.004. This article has 100 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jsb.2013.03.004)